TY  - JOUR
AU  - Salvadores, Natalia
AU  - Moreno-Gonzalez, Ines
AU  - Gamez, Nazaret
AU  - Quiroz, Gabriel
AU  - Vegas-Gomez, Laura
AU  - Escandon, Marcela
AU  - Jimenez, Sebastian
AU  - Vitorica, Javier
AU  - Gutierrez, Antonia
AU  - Soto, Claudio
AU  - Court, Felipe A
PY  - 2022
DO  - 10.1186/s40478-022-01332-9
UR  - http://hdl.handle.net/10668/20373
T2  - Acta neuropathologica communications
AB  - Alzheimer's disease (AD) is a major adult-onset neurodegenerative condition with no available treatment. Compelling reports point amyloid-β (Aβ) as the main etiologic agent that triggers AD. Although there is extensive evidence of detrimental...
LA  - en
PB  - BioMed Central Ltd.
KW  - Alzheimer’s disease
KW  - Amyloid-β oligomers
KW  - Microglia
KW  - Necroptosis
KW  - Neurodegeneration
KW  - Neuroprotection
KW  - Alzheimer Disease
KW  - Amyloid beta-Peptides
KW  - Animals
KW  - Memory Disorders
KW  - Mice
KW  - Microglia
KW  - Necroptosis
TI  - Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer's disease.
TY  - research article
VL  - 10
ER  -